Study / S78Q3K8G62026-04-21

Retracing and rewriting the evolutionary trajectories of mammalian developmental enhancers

Tony Li, Jean-Benoît Lalanne, Emma A. N. Kajiwara, Shruti Jain, Xiaoyi Li et al.

About this study

Cis-regulatory elements (CREs) such as enhancers play a central role in orchestrating mammalian development, yet how they have gained, lost, maintained or changed function over the course of mammalian evolution remains poorly understood. To address this gap, we densely mapped the functional evolution of five mouse developmental enhancers by testing orthologous sequences from 480 extant and ancestrally reconstructed mammalian genomes (Zoonomia, Cactus) with massively parallel reporter assays (MPRAs). This phylogenetic dissection revealed diverse modes of evolution, from lineage-restricted activity to deep functional conservation despite extensive sequence divergence. To pinpoint causal changes, we developed a model-driven reconstitution strategy that uses deep learning-based predictions of chromatin accessibility to re-introduce a succession of mutations into ancestral orthologs; this revealed critical transcription factor binding site (TFBS) changes and pervasive context-dependent epistasis, including instances where mutational effects were strongly contingent on the order of their introduction. When we extended this strategy to tune the activity of extant orthologs, we found that ablation of enhancer function required as few as one to seven mutations, whereas enhancement was constrained by element-specific activity ceilings—a striking asymmetry in the predictability of model-guided enhancer editing. Together, these results shed light on how the plasticity of mammalian enhancers intersects with their evolution, and advance a framework for reprogramming the activity of endogenous CREs at nucleotide resolution.

Full author list & citation

Tony Li, Jean-Benoît Lalanne, Emma A. N. Kajiwara, Shruti Jain, Xiaoyi Li, Tiffany V. Do, Beth K. Martin, Samuel G. Regalado, Riza M. Daza, Jay Shendure. Retracing and rewriting the evolutionary trajectories of mammalian developmental enhancers. 2026-04-21. https://doi.org/10.64898/2026.04.20.719714

Experiments 2

E5O2W2XZ6

PYS-2 MPRA of model-guided and randomized ancestral CRE reconstitution trajectories

A separate episomal 5′ MPRA tested sequential intermediates generated by introducing mouse-derived substitutions and indels into the inferred common mammalian ancestor (Anc239) of the Gata4, Epas1, and Lama1 enhancer tiles. Each trajectory was either ChromBPNet-model ordered or one of ten random mutation orders, with six biological replicates represented by labels 1a, 1b, 2a, 2b, 3a, and 3b.

Episomal Plasmid MPRAMouseGRCm39
Explore data
E6VXMPOS1

PYS-2 MPRA of mammalian CRE orthologs and endogenous CRE tuning trajectories

A pooled episomal 5′ MPRA in mouse PYS-2 cells tested 1,871 extant or reconstructed mammalian orthologs of five 300-bp mouse developmental enhancer tiles together with model-nominated enhancement and ablation trajectories for those enhancers. The deposited library also contained promoter standards and other controls, and was measured in three biological replicates.

Episomal Plasmid MPRAMouseGRCm39
Explore data

Raw source data 33 files

Original supplemental and deposited inputs retained for this study. Download files individually or together as a ZIP; nested folders are preserved. Source reuse terms apply, and sequencing reads may be omitted.

Download all 33 files (ZIP)evo_model_and_random_element_scores.tsv.gzevo_model_and_random_raw_counts.tsv.gzevo_model_and_random_sequence_designs.tsv.gzGSE328309_series.geo.txtIGVFDS1754MDNZ.jsonIGVFDS9730EWQE.jsonmedia-1.xlsxmedia-2.xlsxnihpp-2026.04.20.719714v1-f0001.gifnihpp-2026.04.20.719714v1-f0001.jpgnihpp-2026.04.20.719714v1-f0002.gifnihpp-2026.04.20.719714v1-f0002.jpgnihpp-2026.04.20.719714v1-f0003.gifnihpp-2026.04.20.719714v1-f0003.jpgnihpp-2026.04.20.719714v1-f0004.gifnihpp-2026.04.20.719714v1-f0004.jpgnihpp-2026.04.20.719714v1-f0005.gifnihpp-2026.04.20.719714v1-f0005.jpgnihpp-2026.04.20.719714v1-f0006.gifnihpp-2026.04.20.719714v1-f0006.jpgnihpp-2026.04.20.719714v1-f0007.gifnihpp-2026.04.20.719714v1-f0007.jpgnihpp-2026.04.20.719714v1-f0008.gifnihpp-2026.04.20.719714v1-f0008.jpgnihpp-2026.04.20.719714v1-f0009.gifnihpp-2026.04.20.719714v1-f0009.jpgNIHPP2026.04.20.719714v1-supplement-3.pdfoCRE_and_CRE_optimization_element_scores.tsv.gzoCRE_and_CRE_optimization_raw_counts.tsv.gzoCRE_and_CRE_optimization_sequence_designs.tsv.gzPMC13131660_supplementaryFiles.zippmc_fulltext.xmlsource_notes.txt

Cite OpenMPRA

Cite the OpenMPRA database. Include your access date because the collection changes over time.

Please also cite the source studies when using their data.